| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | $11.9B | $11.1B | $10.1B | $8.9B | $7.1B | $4.8B |
| Cost of Revenue | $8.4B | $8.0B | $7.3B | $6.5B | $5.3B | $3.7B |
| Gross Profit | $3.5B | $3.2B | $2.8B | $2.4B | $1.8B | $1.1B |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | $2.6B | $2.4B | $2.1B | $1.8B | $1.4B | $1.0B |
| Operating Income | $0.1B | $-0.0B | $0.1B | $-0.1B | $-0.1B | $-0.3B |
| Net Income | $0.4B | $0.0B | $0.0B | $-0.1B | $-0.1B | $-0.3B |
| EPS (Basic) | $0.93 | $0.09 | $0.12 | $-0.18 | — | — |
| EPS (Diluted) | $0.91 | $0.09 | $0.12 | $-0.18 | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $3.0B | $3.2B | $2.5B | $2.1B | $1.7B | $0.9B |
| Current Assets | $1.7B | $2.1B | $1.5B | $1.3B | $1.2B | $0.6B |
| Cash & Equivalents | $0.6B | $0.6B | $0.3B | $0.6B | $0.6B | $0.2B |
| Total Liabilities | $2.8B | $2.7B | $2.3B | $2.1B | $1.7B | $1.3B |
| Current Liabilities | $2.2B | $2.1B | $1.8B | $1.6B | $1.4B | $1.1B |
| Stockholders' Equity | $0.3B | $0.5B | $0.2B | $0.0B | $-0.0B | $-0.4B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.3B | $0.2B | $0.1B | $0.0B |
| Investing Cash Flow | $0.4B | $-0.3B | $-0.6B | $-0.2B | $-0.1B | $-0.0B |
| Capital Expenditures | — | — | — | — | — | — |
| Financing Cash Flow | $-1.0B | $0.1B | $-0.0B | $0.0B | $0.3B | $0.1B |